Gisslén Criticizes Public Health Agency for Retraction of Infection Control Guidelines
Magnus Gisslén criticizes FHM for retracting infection control guidelines, citing external pressures.
Key Points
- • Gisslén claims FHM prioritized external relationships over scientific recommendations.
- • The retracted guidelines aimed to control Group A streptococcus and were based on evidence.
- • Concerns have been raised about the medical expertise of FHM's leadership.
- • FHM's secretary defends the agency's decision-making competence.
Magnus Gisslén, the outgoing state epidemiologist, has publicly criticized the Folkhälsomyndigheten (FHM) for retracting crucial infection control recommendations, asserting that the agency prioritized external relationships over scientific integrity. In a recent video, Gisslén expressed disappointment regarding the withdrawal of guidelines designed to prevent the spread of Group A streptococcus infections, which he helped develop. He claims that this retraction was influenced by tensions between FHM and external organizations, specifically the Läkemedelsverket and Strama network.
Gisslén emphasized that maintaining good relations was evidently considered more important than adhering to established science. He also voiced concerns about the diminishing medical expertise within FHM's leadership and questioned the awareness of government ministers regarding the agency's weakening capabilities in infection control. In contrast, FHM's secretary Olivia Wigzell defended the agency's integrity, asserting that their decision-making processes remain competent despite Gisslén's claims of inadequacy.
This controversy over retracted guidelines highlights significant tensions within Swedish public health governance, raising alarms about the future of infection control in the country.